HKEX Insider Activity — 2026-06-23

by hk-insider-activities-daily

🇭🇰 HKEX DI Report — 2026-06-23

🆕 NEW ENTRY — 1208 MMG ← JPMorgan Chase, now 5.77% (increased by 0.92pp from prior filing), acquired 111,976,735 shares @ HKD 8.52, HK$954.2M Read: JPMorgan crossed the 5% threshold in copper-zinc miner MMG (a China Minmetals subsidiary) with a near-HK$1B aggregate — consistent with prime-brokerage accumulation riding structural metals demand in the energy-transition cycle.

🆕 NEW ENTRY — 2628 China Life Insurance ← FMR LLC (Fidelity), now 5.07% (increased by 0.10pp from prior filing), acquired 7,506,000 H shares @ HKD 30.05, HK$225.6M Read: Fidelity's FMR just crossed the 5% line in mainland China's largest life insurer as H-shares re-rate on expectations that lower long-end rates will boost embedded-value multiples.

🆕 NEW ENTRY — 585 Imagi International Holdings ← Yanying Ma (via Goldpalm Offshore; dual cascade filing), now 10.00% (first-time entry at 10.00pp; event dated 2026-04-18, filed late), acquired 82,960,000 shares @ HKD 2.70, HK$224.0M Read: Yanying Ma took a cornerstone-scale 10% stake in animation studio Imagi International through offshore vehicle Goldpalm — a HK$224M commitment filed roughly two months after the April trade date, flagging a strategic not a passive intent.

🆕 NEW ENTRY — 1801 Innovent Biologics ← JPMorgan Chase, now 5.01% (increased by 0.06pp from prior filing), acquired 1,068,875 shares @ HKD 75.40, HK$80.6M Read: JPMorgan barely cleared the 5% line in leading China biopharma Innovent, whose PD-1, PCSK9, and biosimilar pipeline has drawn renewed institutional attention as oncology assets globally re-rate.

🆕 NEW ENTRY — 895 Dongjiang Environmental ← Barclays, now 11.64% (increased by 11.06pp from prior filing), acquired 22,120,200 H shares @ HKD 1.967, HK$43.5M Read: Barclays disclosed an outsized 11.64% aggregate in hazardous-waste manager Dongjiang Environmental — the near-11pp step-up from the prior undisclosed level implies concentrated rapid accumulation in a name below most institutional radars.

🆕 NEW ENTRY — 3759 Pharmaron ← JPMorgan Chase, now 5.20% (increased by 0.43pp from prior filing), acquired 1,555,986 shares @ HKD 15.20, HK$23.7M Read: JPMorgan crossed 5% in contract research and manufacturing firm Pharmaron Beijing, part of a wave of institutional re-entry into Chinese CRO/CDMO names that have de-rated sharply since their 2021 highs.

🆕 NEW ENTRY — 1164 CGN Mining ← Van Eck Associates, now 5.06% (increased by 0.08pp from prior filing), acquired 6,495,000 shares @ HKD 3.05, HK$19.8M Read: ETF specialist Van Eck — operator of the VanEck Uranium+Nuclear ETF family — crossed 5% in CGN Mining (nuclear fuel procurement arm of China General Nuclear Power), signalling fresh inflows into the uranium and nuclear supply-chain trade.

🆕 NEW ENTRY — 1072 Dongfang Electric ← Goldman Sachs, now 5.10% (increased by 0.16pp from prior filing), acquired 613,000 shares @ HKD 25.95, HK$15.9M Read: Goldman Sachs crossed 5% in power-equipment maker Dongfang Electric on the same date BNY Mellon's internal restructuring also surfaced a 5.19% aggregate — twin institutional signals on the same session reinforce the energy-transition re-rating narrative for this name.

🆕 NEW ENTRY — 187 Beijing Jingcheng Machinery Electric ← Barclays, now 6.75% (increased by 2.84pp from prior filing), acquired 2,846,000 H shares @ HKD 3.67, HK$10.4M Read: Barclays disclosed a 6.75% stake in Beijing Jingcheng Machinery Electric with a nearly 3pp step-up in a single filing, suggesting the disclosure captures the tail end of a sub-threshold accumulation campaign in the small-cap H-share industrial.

🆕 NEW ENTRY — 3347 Tigermed ← Sun Life / MFS (cascade filing: Sun Life Financial Inc., Sun Life of Canada (U.S.) Financial Services Holdings, and Massachusetts Financial Services Company all reporting one underlying block), now 5.14% (increased by 0.20pp from prior filing), acquired 244,700 shares @ HKD 31.11, HK$7.6M Read: Canadian insurance group Sun Life and its MFS asset management arm crossed 5% in CRO Tigermed, filing simultaneously at three levels of their holding structure — one position, three disclosures — in an entry that pairs with FMR's China Life stake as evidence of Canadian institutional rotation into China healthcare.

🆕 NEW ENTRY — 1304 Fortior Technology ← Zhuque Fund Management, now 5.14% (increased by 0.18pp from prior filing), acquired 37,200 H shares @ HKD 121.35, HK$4.5M Read: Chinese domestic fund manager Zhuque crossed the 5% disclosure line in motor-driver chipmaker Fortior Technology's H shares, a niche EV component play gaining domestic fund attention as China's automotive chip localisation push accelerates.

🆕 NEW ENTRY — 6831 Green Tea Group ← Morgan Stanley, now 5.04% (increased by 0.08pp from prior filing), acquired 538,473 shares @ HKD 6.64, HK$3.6M Read: Morgan Stanley tipped just over the 5% threshold in casual-dining chain Green Tea Group with a wafer-thin margin above the line — points to passive or prime-brokerage book-building rather than a high-conviction directional entry in the consumer recovery trade.

🆕 NEW ENTRY — 2315 Biocytogen Pharmaceuticals ← BNY Mellon (entity reclassification, reason 1004; aggregate now 5.18%, increased by 4.05pp) Read: BNY Mellon's large internal entity consolidation lifted its Biocytogen aggregate to 5.18% in a 4pp bookkeeping step-up — not open-market buying, but it confirms meaningful custodial exposure to the preclinical CRO/biotech.

🆕 NEW ENTRY — 1072 Dongfang Electric ← BNY Mellon (entity reclassification, reason 1004; aggregate now 5.19%, increased by 0.44pp) Read: BNY Mellon's internal re-allocation across subsidiaries lifted its Dongfang Electric aggregate to 5.19% — not open-market buying, but directionally consistent with Goldman Sachs's same-day market entry in the name.

🆕 NEW ENTRY — 358 Jiangxi Copper ← BlackRock (entity reclassification, reason 1004; aggregate now 5.52%, increased by 1.00pp) Read: BlackRock's internal entity reshuffle raised its Jiangxi Copper H-share aggregate to 5.52% — not an open-market purchase, though the constructive directional drift pairs with copper's structural tailwinds from grid and EV demand.

🆕 NEW ENTRY — 358 Jiangxi Copper ← BNY Mellon (entity reclassification, reason 1004; aggregate now 5.00%, increased by 0.85pp) Read: BNY Mellon separately reclassified its Jiangxi Copper position to land right at the 5.00% disclosure floor — twin custodian restructurings in the same copper H-share within days suggest related settlement or custody-transfer activity between the two institutions.

🆕 NEW ENTRY — 9626 Bilibili (W) ← BlackRock (entity reclassification, reason 1004; aggregate now 5.14%, increased by 0.19pp) Read: BlackRock's internal sub-entity reshuffle nudged its Bilibili aggregate just above 5% — a bookkeeping re-allocation rather than a new buy in the video-streaming and gaming platform, though BlackRock's continuing presence at this scale is worth noting for positioning watchers.